The Biopharma CEO Confidence Index is a forward-looking indicator designed to measure C-suite sentiment and confidence in the biopharma industry’s economy.
The BCI measures c-suite and executive leadership sentiment in the biopharma industry asking questions about their confidence levels concerning key issues. We look for the BCI to become a valuable and highly sought-after resource for its key insights across both key industry-related issues and business functions:
- Capital Markets
- Deal Landscape
- Mergers and Acquisitions
- Clinical Development
- Regulatory Affairs
- Commercialization
- Business Model and Workforce
Click Here to view the results of the 2020 Q1 BCI Index